Synuclein Gamma Inhibits the Mitotic Checkpoint Function and Promotes Chromosomal Instability of Breast Cancer CellsSatoru Inaba, Jingwen Liu, Cong Li et al.|Breast Cancer Research and Treatment|2005Cited by 83
A phase 1 dose-escalation study of intravenously (IV) administered TAK-676, a novel STING agonist, alone and in combination with pembrolizumab in patients (pts) with advanced or metastatic solid tumors.Gerald S. Falchook, Anthony J. Olszanski, Patricia LoRusso et al.|Journal of Clinical Oncology|2021Cited by 10